Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase

Journal of Immunology

Volumn 186, Issue 8, 2011, Pages 4915-4924

  Fan, Huapeng ^a   Hall, Pam ^a   Santos, Leilani L ^a,d   Gregory, Julia L ^a   Fingerle Rowson, Gunter ^b   Bucala, Richard ^c   Morand, Eric F ^a   Hickey, Michael J ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD74 ANTIGEN; MACROPHAGE CHEMOTACTIC FACTOR; MACROPHAGE MIGRATION INHIBITION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ACTIN POLYMERIZATION; ANIMAL EXPERIMENT; ARTICLE; CELL ADHESION; CHEMOKINESIS; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IMMUNOREGULATION; IN VIVO STUDY; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; BLOTTING, WESTERN; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; DUAL SPECIFICITY PHOSPHATASE 1; HISTOCOMPATIBILITY ANTIGENS CLASS II; LEUKOCYTES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHO GTP-BINDING PROTEINS;

EID: 79954998838     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003713     Document Type: Article

References (75)

1. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-314. (Pubitemid 24046692)
2. Ley, K., C. Laudanna, M. I. Cybulsky, and S. Nourshargh. 2007. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7:678-689. (Pubitemid 47327397)
3. Phillipson, M., B. Heit, P. Colarusso, L. Liu, C. M. Ballantyne, and P. Kubes. 2006. Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade. J. Exp. Med. 203:2569-2575. (Pubitemid 44833334)
4. Khandoga, A. G., A. Khandoga, C. A. Reichel, P. Bihari, M. Rehberg, and F. Krombach. 2009. In vivo imaging and quantitative analysis of leukocyte directional migration and polarization in inflamed tissue. PLoS ONE 4: e4693.
5. Foxman, E. F., J. J. Campbell, and E. C. Butcher. 1997. Multistep navigation and the combinatorial control of leukocyte chemotaxis. J. Cell Biol. 139:1349-1360. (Pubitemid 27523220)
6. Foxman, E. F., E. J. Kunkel, and E. C. Butcher. 1999. Integrating conflicting chemotactic signals: the role of memory in leukocyte navigation. J. Cell Biol. 147:577-588.
7. Heit, B., S. M. Robbins, C. M. Downey, Z. Guan, P. Colarusso, B. J. Miller, F. R. Jirik, and P. Kubes. 2008. PTEN functions to " prioritize" chemotactic cues and prevent "distraction" in migrating neutrophils. Nat. Immunol. 9:743-752. (Pubitemid 351859157)
8. Kinashi, T. 2005. Intracellular signalling controlling integrin activation in lymphocytes. Nat. Rev. Immunol. 5:546-559. (Pubitemid 40961332)
9. 2 integrin-mediated rolling on intercellular adhesion molecule-1. Immunity 26:773-783. (Pubitemid 46907666)
10. Wang, H. B., J. T. Wang, L. Zhang, Z. H. Geng, W. L. Xu, T. Xu, Y. Huo, X. Zhu, E. F. Plow, M. Chen, and J. G. Geng. 2007. P-selectin primes leukocyte integrin activation during inflammation. Nat. Immunol. 8:882-892. (Pubitemid 47099040)
11. Heit, B., S. Tavener, E. Raharjo, and P. Kubes. 2002. An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J. Cell Biol. 159:91-102. (Pubitemid 35191521)
12. Ashida, N., H. Arai, M. Yamasaki, and T. Kita. 2001. Distinct signaling pathways for MCP-1-dependent integrin activation and chemotaxis. J. Biol. Chem. 276:16555-16560.
13. Cara, D. C., J. Kaur, M. Forster, D. M. McCafferty, and P. Kubes. 2001. Role of p38 mitogen-activated protein kinase in chemokine-induced emigration and chemotaxis in vivo. J. Immunol. 167:6552-6558. (Pubitemid 33081591)
14. Turner, S. J., J. Domin, M. D. Waterfield, S. G. Ward, and J. Westwick. 1998. The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2a. J. Biol. Chem. 273:25987-25995. (Pubitemid 28475831)
15. Moldobaeva, A., A. Baek, and E. M. Wagner. 2008. MIP-2 causes differential activation of RhoA in mouse aortic versus pulmonary artery endothelial cells. Microvasc. Res. 75:53-58. (Pubitemid 350266740)
16. Gerszten, R. E., E. B. Friedrich, T. Matsui, R. R. Hung, L. Li, T. Force, and A. Rosenzweig. 2001. Role of phosphoinositide 3-kinase in monocyte recruitment under flow conditions. J. Biol. Chem. 276:26846-26851.
17. Fuhler, G. M., G. J. Knol, A. L. Drayer, and E. Vellenga. 2005. Impaired interleukin-8-and GROa-induced phosphorylation of extracellular signalregulated kinase result in decreased migration of neutrophils from patients with myelodysplasia. J. Leukoc. Biol. 77:257-266. (Pubitemid 40326224)
18. Morand, E. F., M. Leech, and J. Bernhagen. 2006. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat. Rev. Drug Discov. 5:399-410.
19. Santos, L. L., and E. F. Morand. 2009. Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis. Clin. Chim. Acta 399:1-7.
20. Bernhagen, J., T. Calandra, R. A. Mitchell, S. B. Martin, K. J. Tracey, W. Voelter, K. R. Manogue, A. Cerami, and R. Bucala. 1993. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365:756-759. (Pubitemid 23339882)
21. Kobayashi, M., Y. Nasuhara, A. Kamachi, Y. Tanino, T. Betsuyaku, E. Yamaguchi, J. Nishihira, and M. Nishimura. 2006. Role of macrophage migration inhibitory factor in ovalbumin-induced asthma in rats. Eur. Respir. J. 27:726-734. (Pubitemid 44914195)
22. Leech, M., C. Metz, L. Santos, T. Peng, S. R. Holdsworth, R. Bucala, and E. F. Morand. 1998. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum. 41:910-917. (Pubitemid 28225792)
23. Pan, J. H., G. K. Sukhova, J. T. Yang, B. Wang, T. Xie, H. Fu, Y. Zhang, A. R. Satoskar, J. R. David, C. N. Metz, et al. 2004. Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 109:3149-3153.
24. Denkinger, C. M., M. Denkinger, J. J. Kort, C. Metz, and T. G. Forsthuber. 2003. In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system. J. Immunol. 170:1274-1282. (Pubitemid 36139493)
25. Gregory, J. L., E. F. Morand, S. J. McKeown, J. A. Ralph, P. Hall, Y. H. Yang, S. R. McColl, and M. J. Hickey. 2006. Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2. J. Immunol. 177:8072-8079. (Pubitemid 44846325)
26. Bernhagen, J., R. Krohn, H. Lue, J. L. Gregory, A. Zernecke, R. R. Koenen, M. Dewor, I. Georgiev, A. Schober, L. Leng, et al. 2007. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13:587-596. (Pubitemid 46828480)
27. Burger-Kentischer, A., H. Goebel, R. Seiler, G. Fraedrich, H. E. Schaefer, S. Dimmeler, R. Kleemann, J. Bernhagen, and C. Ihling. 2002. Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation 105:1561-1566. (Pubitemid 34297633)
28. Gregory, J. L., M. T. Leech, J. R. David, Y. H. Yang, A. Dacumos, and M. J. Hickey. 2004. Reduced leukocyte-endothelial cell interactions in the inflamed microcirculation of macrophage migration inhibitory factor-deficient mice. Arthritis Rheum. 50:3023-3034. (Pubitemid 39209542)
29. Gregory, J. L., P. Hall, M. Leech, E. F. Morand, and M. J. Hickey. 2009. Independent roles of macrophage migration inhibitory factor and endogenous, but not exogenous glucocorticoids in regulating leukocyte trafficking. Microcirculation 16:735-748.
30. Cheng, Q., S. J. McKeown, L. Santos, F. S. Santiago, L. M. Khachigian, E. F. Morand, and M. J. Hickey. 2010. Macrophage migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion molecules. J. Immunol. 185:1238-1247.
31. Toh, M. L., D. Aeberli, D. Lacey, Y. Yang, L. L. Santos, M. Clarkson, L. Sharma, C. Clyne, and E. F. Morand. 2006. Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factor. J. Immunol. 177:4818-4825. (Pubitemid 44469817)
32. Aeberli, D., Y. Yang, A. Mansell, L. Santos, M. Leech, and E. F. Morand. 2006. Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-1 and p38 MAP kinase. FEBS Lett. 580:974-981. (Pubitemid 43152322)
33. Santos, L. L., A. Dacumos, J. Yamana, L. Sharma, and E. F. Morand. 2008. Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation. Clin. Exp. Immunol. 152:372-380. (Pubitemid 351522760)
34. Lue, H., M. Thiele, J. Franz, E. Dahl, S. Speckgens, L. Leng, G. Fingerle-Rowson, R. Bucala, B. Lüscher, and J. Bernhagen. 2007. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene 26:5046-5059. (Pubitemid 47206949)
35. Gore, Y., D. Starlets, N. Maharshak, S. Becker-Herman, U. Kaneyuki, L. Leng, R. Bucala, and I. Shachar. 2008. Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J. Biol. Chem. 283:2784-2792.
36. Leng, L., C. N. Metz, Y. Fang, J. Xu, S. Donnelly, J. Baugh, T. Delohery, Y. Chen, R. A. Mitchell, and R. Bucala. 2003. MIF signal transduction initiated by binding to CD74. J. Exp. Med. 197:1467-1476. (Pubitemid 36686708)
37. Takahashi, K., K. Koga, H. M. Linge, Y. Zhang, X. Lin, C. N. Metz, Y. Al-Abed, K. Ojamaa, and E. J. Miller. 2009. Macrophage CD74 contributes to MIF-induced pulmonary inflammation. Respir. Res. 10:33.
38. Marsh, L. M., L. Cakarova, G. Kwapiszewska, W. von Wulffen, S. Herold, W. Seeger, and J. Lohmeyer. 2009. Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair. Am. J. Physiol. Lung Cell. Mol. Physiol. 296: L442-L452.
39. Fingerle-Rowson, G., O. Petrenko, C. N. Metz, T. G. Forsthuber, R. Mitchell, R. Huss, U. Moll, W. Müller, and R. Bucala. 2003. The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc. Natl. Acad. Sci. USA 100:9354-9359. (Pubitemid 37033932)
40. Shachar, I., and R. A. Flavell. 1996. Requirement for invariant chain in B cell maturation and function. Science 274:106-108. (Pubitemid 26332735)
41. Apostolopoulos, J., M. J. Hickey, L. Sharma, P. Davenport, L. Moussa, W. G. James, J. L. Gregory, A. R. Kitching, M. Li, and P. G. Tipping. 2008. The cytoplasmic domain of tissue factor in macrophages augments cutaneous delayed-type hypersensitivity. J. Leukoc. Biol. 83:902-911. (Pubitemid 351959870)
42. Kong, X. N., H. X. Yan, L. Chen, L. W. Dong, W. Yang, Q. Liu, L. X. Yu, D. D. Huang, S. Q. Liu, H. Liu, et al. 2007. LPS-induced down-regulation of signal regulatory protein α contributes to innate immune activation in macrophages. J. Exp. Med. 204:2719-2731. (Pubitemid 350044794)
43. Falk, W., R. H. Goodwin, Jr., and E. J. Leonard. 1980. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J. Immunol. Methods 33:239-247.
44. Tacke, F., D. Alvarez, T. J. Kaplan, C. Jakubzick, R. Spanbroek, J. Llodra, A. Garin, J. Liu, M. Mack, N. van Rooijen, et al. 2007. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117:185-194. (Pubitemid 46048465)
45. Santos, L. L., D. Lacey, Y. Yang, M. Leech, and E. F. Morand. 2004. Activation of synovial cell p38 MAP kinase by macrophage migration inhibitory factor. J. Rheumatol. 31:1038-1043. (Pubitemid 38715876)
46. Pattabiraman, P. P., and P. V. Rao. 2010. Mechanistic basis of Rho GTPaseinduced extracellular matrix synthesis in trabecular meshwork cells. Am. J. Physiol. Cell Physiol. 298: C749-C763.
47. Cho, I. J., N. R. Woo, and S. G. Kim. 2008. The identification of C/EBPβ as a transcription factor necessary for the induction of MAPK phosphatase-1 by Toll-like receptor-4 ligand. Arch. Biochem. Biophys. 479:88-96.
48. Yang, Y. H., P. Hall, G. Milenkovski, L. Sharma, P. Hutchinson, E. Melis, P. Carmeliet, P. Tipping, and E. Morand. 2004. Reduction in arthritis severity and modulation of immune function in tissue factor cytoplasmic domain mutant mice. Am. J. Pathol. 164:109-117. (Pubitemid 38364596)
49. Faure-André, G., P. Vargas, M. I. Yuseff, M. Heuzé, J. Diaz, D. Lankar, V. Steri, J. Manry, S. Hugues, F. Vascotto, et al. 2008. Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain. Science 322:1705-1710.
50. Hannigan, M., L. Zhan, Z. Li, Y. Ai, D. Wu, and C. K. Huang. 2002. Neutrophils lacking phosphoinositide 3-kinase γ show loss of directionality during N-formyl-Met-Leu-Phe-induced chemotaxis. Proc. Natl. Acad. Sci. USA 99:3603-3608. (Pubitemid 34252153)
51. Friedl, P., and B. Weigelin. 2008. Interstitial leukocyte migration and immune function. Nat. Immunol. 9:960-969.
52. Ottonello, L., F. Montecucco, M. Bertolotto, N. Arduino, M. Mancini, A. Corcione, V. Pistoia, and F. Dallegri. 2005. CCL3 (MIP-1α) induces in vitro migration of GM-CSF-primed human neutrophils via CCR5-dependent activation of ERK 1/2. Cell. Signal. 17:355-363. (Pubitemid 39574696)
53. Swant, J. D., B. E. Rendon, M. Symons, and R. A. Mitchell. 2005. Rho GTPasedependent signaling is required for macrophage migration inhibitory factormediated expression of cyclin D1. J. Biol. Chem. 280:23066-23072. (Pubitemid 40853217)
54. Roger, T., A. L. Chanson, M. Knaup-Reymond, and T. Calandra. 2005. Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. Eur. J. Immunol. 35:3405-3413. (Pubitemid 43025521)
55. Ralph, J. A., A. U. Ahmed, L. L. Santos, A. R. Clark, J. McMorrow, E. P. Murphy, and E. F. Morand. 2010. Identification of NURR1 as a mediator of MIF signaling during chronic arthritis: effects on glucocorticoid-induced MKP1. Am. J. Pathol. 177:2366-2378.
56. Roger, T., J. David, M. P. Glauser, and T. Calandra. 2001. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414:920-924. (Pubitemid 34024744)
57. Liu, L., C. Ji, J. Chen, Y. Li, X. Fu, Y. Xie, S. Gu, and Y. Mao. 2008. A global genomic view of MIF knockdown-mediated cell cycle arrest. Cell Cycle 7:1678-1692. (Pubitemid 351881336)
58. Shi, X., L. Leng, T. Wang, W. Wang, X. Du, J. Li, C. McDonald, Z. Chen, J. W. Murphy, E. Lolis, et al. 2006. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25:595-606. (Pubitemid 44529040)
59. Bizzarri, C., S. Pagliei, L. Brandolini, P. Mascagni, G. Caselli, P. Transidico, S. Sozzani, and R. Bertini. 2001. Selective inhibition of interleukin-8-induced neutrophil chemotaxis by ketoprofen isomers. Biochem. Pharmacol. 61:1429-1437. (Pubitemid 32452359)
60. Zu, Y. L., J. Qi, A. Gilchrist, G. A. Fernandez, D. Vazquez-Abad, D. L. Kreutzer, C. K. Huang, and R. I. Sha'afi. 1998. p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-α or FMLP stimulation. J. Immunol. 160:1982-1989. (Pubitemid 28106489)
61. Lacey, D., A. Sampey, R. Mitchell, R. Bucala, L. Santos, M. Leech, and E. Morand. 2003. Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum. 48:103-109. (Pubitemid 36091654)
62. Amin, M. A., O. V. Volpert, J. M. Woods, P. Kumar, L. A. Harlow, and A. E. Koch. 2003. Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ. Res. 93:321-329. (Pubitemid 37048244)
63. Hippenstiel, S., S. Soeth, B. Kellas, O. Fuhrmann, J. Seybold, M. Krüll, C. Eichel-Streiber, M. Goebeler, S. Ludwig, and N. Suttorp. 2000. Rho proteins and the p38-MAPK pathway are important mediators for LPS-induced interleukin-8 expression in human endothelial cells. Blood 95:3044-3051. (Pubitemid 30321152)
64. Ralph, J. A., A. U. Ahmed, L. L. Santos, A. R. Clark, J. McMorrow, E. P. Murphy, and E. F. Morand. 2010. Identification of NURR1 as a mediator of MIF signaling during chronic arthritis: effects on glucocorticoid-induced MKP1. Am. J. Pathol. 177:2366-2378.
65. Fürst, R., C. Brueckl, W. M. Kuebler, S. Zahler, F. Krötz, A. Görlach, A. M. Vollmar, and A. K. Kiemer. 2005. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD (P) H oxidase/Nox2-activation. Circ. Res. 96:43-53. (Pubitemid 40095753)
66. Patterson, K. I., T. Brummer, P. M. O'Brien, and R. J. Daly. 2009. Dualspecificity phosphatases: critical regulators with diverse cellular targets. Biochem. J. 418:475-489.
67. Calandra, T., J. Bernhagen, R. A. Mitchell, and R. Bucala. 1994. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179:1895-1902. (Pubitemid 24155670)
68. Starlets, D., Y. Gore, I. Binsky, M. Haran, N. Harpaz, L. Shvidel, S. Becker-Herman, A. Berrebi, and I. Shachar. 2006. Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood 107:4807-4816. (Pubitemid 43882632)
69. Binsky, I., M. Haran, D. Starlets, Y. Gore, F. Lantner, N. Harpaz, L. Leng, D. M. Goldenberg, L. Shvidel, A. Berrebi, et al. 2007. IL-8 secreted in a macrophage migration-inhibitory factor-and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival. Proc. Natl. Acad. Sci. USA 104:13408-13413. (Pubitemid 47293958)
70. Beswick, E. J., I. V. Pinchuk, G. Suarez, J. C. Sierra, and V. E. Reyes. 2006. Helicobacter pylori CagA-dependent macrophage migration inhibitory factor produced by gastric epithelial cells binds to CD74 and stimulates procarcinogenic events. J. Immunol. 176:6794-6801. (Pubitemid 43787862)
71. Vera, P. L., X. Wang, R. J. Bucala, and K. L. Meyer-Siegler. 2009. Intraluminal blockade of cell-surface CD74 and glucose regulated protein 78 prevents substance P-induced bladder inflammatory changes in the rat. PLoS ONE 4: e5835.
72. Schwartz, V., H. Lue, S. Kraemer, J. Korbiel, R. Krohn, K. Ohl, R. Bucala, C. Weber, and J. Bernhagen. 2009. A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett. 583:2749-2757.
73. Lue, H., M. Dewor, L. Leng, R. Bucala, and J. Bernhagen. 2011. Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Cell. Signal. 23:135-144.
74. Barrilleaux, B. L., B. W. Fischer-Valuck, J. K. Gilliam, D. G. Phinney, and K. C. O'Connor. 2010. Activation of CD74 inhibits migration of human mesenchymal stem cells. In Vitro Cell. Dev. Biol. Anim. 46:566-572.
75. Binsky, I., F. Lantner, V. Grabovsky, N. Harpaz, L. Shvidel, A. Berrebi, D. M. Goldenberg, L. Leng, R. Bucala, R. Alon, et al. 2010. TAp63 regulates VLA-4 expression and chronic lymphocytic leukemia cell migration to the bone marrow in a CD74-dependent manner. J. Immunol. 184:4761-4769.